Fig. 5

Evaluation of identified candidate diagnostic biomarkers in HGSOC. A, B Comparison of receiver operating characteristic (ROC) curves from IBP2_LEG, IBP2_LIQ, TIMP1_GFQ, and combinations of the three peptides in non-cancerous vs. late-stage and benign vs. late-stage sera. C, D Summary of diagnostic performance of IBP2_LEG, IBP2_LIQ, TIMP1_GFQ, and combinations of the three peptides in non-cancerous vs. late-stage and benign vs. late-stage sera